Administration of arginine-vasotocin (AVT) to human subjects.
D000328:Adult; D005133:Eye Movements / Q000187:drug effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D010870:Pineal Gland / Q000187:drug effects* / Q000378:metabolism; D011388:Prolactin / Q000097:blood; D012894:Sleep Stages / Q000187:drug effects; D013972:Thyrotropin / Q000097:blood / Q000494:pharmacology; D014668:Vasotocin / Q000494:pharmacology*
D007987:Gonadotropin-Releasing Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin; D014668:Vasotocin